UMass

RNAi researcher Anastasia Khvorova has joined the RNA Therapeutics Institute at the University of Massachusetts Medical School as a professor of molecular medicine.

The University of Utah this month took steps to keep its RNAi intellectual property lawsuit on track after the defendants in the case sought a stay of proceedings, arguing that discovery in the litigation should proceed while certain jurisdictional issues are resolved.

Silence Therapeutics said this week that it plans to raise as much as £5.7 million ($8.8 million) through the issuance of up to around 940 million new ordinary shares.

Roughly one week after a US District Court rejected the efforts of University of Massachusetts officials to have an intellectual property lawsuit filed against them dismissed, the UMass defendants have filed an appeal with a federal court to re-examine the issue.

A Massachusetts District Court this week denied motions to dismiss an intellectual property-ownership lawsuit filed by the University of Utah against Alnylam Pharmaceuticals and several University of Massachusetts officials, among others, telling the defendants that they have not

The University of Utah last week fired back at a bid by University of Massachusetts officials to have an RNAi technology intellectual property lawsuit dismissed, arguing that the court hearing the case — and not the US Supreme Court, as the officials contend — is the appropriate

By Molika Ashford